Evidence map›Paper›PMID 32684648›Full record

ReviewReumatologia2020

The changing role of ultrasonography examination in patients with rheumatoid arthritis in light of recent studies.

Marta Dura, Paweł Żuchowski, Przemysław Gorgolewski, Marzena Waszczak-Jeka, Sławomir Jeka

Abstract readReview
In one paragraph

Review in Reumatologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marta DuraDepartment of Radiology and Imaging Diagnostics, Dr Jan Biziel University Hospital No. 2 in Bydgoszcz, Poland.
Paweł ŻuchowskiDepartment of Rheumatology and Connective Tissue Diseases, Dr Jan Biziel University Hospital No. 2 in Bydgoszcz, Poland.
Przemysław GorgolewskiDepartment of Radiology and Imaging Diagnostics, Dr Jan Biziel University Hospital No. 2 in Bydgoszcz, Poland.
Marzena Waszczak-JekaNon-public Health Care Centre "Nasz Lekarz", Toruń, Poland.
Sławomir JekaLudwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For many years, ultrasonography (US) has been a widely accepted modality used for joint assessment in patients with rheumatoid arthritis (RA). Given the efficacy of present day therapies, there is scepticism whether it is required in the first place. The most recent clinical Targeting synovitis in Early Rheumatoid Arthritis (TaSER) and Clinical Tight Control Therapy (ARCTIC) trials' results appear to contradict it, yet this does not necessarily mean ultrasound has no place in modern rheumatology. The possibility of detecting inflammation at a subclinical level carries a tremendous predictive value, enabling identification of patients likely to experience an exacerbation in the coming months. Therefore, US should be a part of the decision-making process regarding treatment modification or introduction of any additional interventions, such as glucocorticosteroid injections. The results of the most recent clinical trials do not negate the usefulness of US, but merely suggest that it ought to be used in moderation.

Indexed as

inflammationrheumatoid arthritissynovitisultrasonography

Identifiers

PMID32684648
PMCPMC7362270

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.